Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase

¹Antiviral Therapeutic Research Unit, Wellcome Research Laboratories, Beckenham, Kent, U.K.

The Journal of General Virology

|May 1, 1994

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

A comparison of computational models with and without genotyping for prediction of response to second-line HIV therapy.

HIV medicine·2014

Same author

Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings.

The Journal of antimicrobial chemotherapy·2013

Same author

Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings.

The Journal of antimicrobial chemotherapy·2010

Same author

Crystal structures of Zidovudine- or Lamivudine-resistant human immunodeficiency virus type 1 reverse transcriptases containing mutations at codons 41, 184, and 215.

Journal of virology·2002

Same author

Phenotypic susceptibilities to tenofovir in a large panel of clinically derived human immunodeficiency virus type 1 isolates.

Antimicrobial agents and chemotherapy·2002

Same author

Mutational patterns in the HIV genome and cross-resistance following nucleoside and nucleotide analogue drug exposure.

Antiviral therapy·2001